The Next Steps to Achieve Drug Price Transparency
Kyle Kiser, CEO of Arrive Health, a technology partner for health systems, pharmacies, and insurers that provides drug pricing and insurance coverage data, discusses the Centers for Medicare & Medicaid Services (CMS) enforcement of the Hospital & Health Plan Price Transparency Bills and why the legislation is just a starting point for making healthcare pricing less opaque. He talks about the next steps care providers can take beyond the transparency bills to change physician/pharmacist/patient behaviors and drive more affordable care.
Kyle is responsible for setting the strategic direction of RxRevu and manages company-wide initiatives, operations, and resources.
Kyle brings more than 15 years of healthcare expertise within the payer, provider, and employer spaces. He has helped to develop incentive strategies for some of the country’s most innovative employers and led product launches with some of the nation’s largest payers. Prior to joining RxRevu, he was an early employee at Welltok and Catapult Health, as well as Director of Sales at Principal Wellness Company, which gave him a unique perspective on how to grow early-stage healthcare tech companies within the value chain.
A graduate from Guilford College, Kyle holds a Bachelor of Science in business. He is a lover of the outdoors as well as folk and bluegrass music. He resides in Seattle with his wife, Carly, and two children, Audrey and Jack.
